Millipore extends chromatography offering; Merck takeover cleared by EU

- Last updated on GMT

Related tags: Millipore

Millipore is targeting protein manufacturers with a new chromatography resin that, the firm claims, offers flexibility and high throughput with a small manufacturing footprint.

The product, named ProRes-S media, was developed in collaboration with Dow Chemical as a mono-dispersed polymethacrylate strong cation exchange resin designed with the production of monoclonal antibodies (MAbs) in mind.

Paul Chapman, VP of downstream processing unit, said: “Combining Millipore's expertise in purification with Dow's extensive experience in ion-exchange resins technology allows us to offer biopharmaceutical manufacturers a substantially expanded chromatography solution​."

Millipore also claim the resin offers a broader operating window over a wider range of conductivities than available medias and is optimized for resolving difficult impurities.

Merck takeover approved

In other news, European regulators have approved Merck KGaA's proposed $7.2bn (EUR5.6bn) acquisition of Millipore. The deal, announced in March​, is part of the German drugmaker's effort to add bioprocessing and bioscience expertise to its chemical and active pharmaceutical ingredient (API) production business.

Related topics: Downstream Processing

Related news

Show more

Follow us

Products

View more

Webinars